RALEIGH, N.C. — 09.23.2026 — ClearSens, Inc, an ultrasound technology company specializing in advanced transducer, imaging, and sensing solutions, is contributing to the Defense Advanced Research Projects Agency’s (DARPA) Medics Autonomously Stopping Hemorrhage (MASH) program (https://www.darpa.mil/research/programs/medics-autonomously-stopping-hemorrhage) as a subcontractor to Teledyne Scientific & Imaging, LLC. The program seeks to advance technologies capable of autonomous